CLINICAL_TRIALS
trial_result
· 2024-12-04
Clinical Trial Update: UTOLA: UTerin OLAparib [Phase 2]
Summary
Phase 2 trial of olaparib for endometrial cancer has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ARCAGY/ GINECO GROUP | Conditions: Endometrial Carcinoma | Phase 2 | Status: COMPLETED